Plasma procoagulant phospholipid clotting time and venous thromboembolism risk

Background - Negatively charged procoagulant phospholipids, phosphatidylserine (PS) in particular, are vital to coagulation and expressed on the surface membrane of extracellular vesicles. No previous study has investigated the association between plasma procoagulant phospholipid clotting time (PPL...

Full description

Bibliographic Details
Published in:Research and Practice in Thrombosis and Haemostasis
Main Authors: Ramberg, Cathrine, Wilsgård, line, Latysheva, Nadezhda, Brækkan, Sigrid Kufaas, Hindberg, Kristian, Sovershaev, Timofey, Snir, Omri, Hansen, John Bjarne
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2021
Subjects:
Online Access:https://hdl.handle.net/10037/23804
https://doi.org/10.1002/rth2.12640
id ftunivtroemsoe:oai:munin.uit.no:10037/23804
record_format openpolar
spelling ftunivtroemsoe:oai:munin.uit.no:10037/23804 2023-05-15T18:34:45+02:00 Plasma procoagulant phospholipid clotting time and venous thromboembolism risk Ramberg, Cathrine Wilsgård, line Latysheva, Nadezhda Brækkan, Sigrid Kufaas Hindberg, Kristian Sovershaev, Timofey Snir, Omri Hansen, John Bjarne 2021-12-20 https://hdl.handle.net/10037/23804 https://doi.org/10.1002/rth2.12640 eng eng Wiley Research and Practice in Thrombosis and Haemostasis Ramberg, Wilsgård, Latysheva, Brækkan, Hindberg, Sovershaev, Snir, Hansen. Plasma procoagulant phospholipid clotting time and venous thromboembolism risk. Research and Practice in Thrombosis and Haemostasis. 2021;5(8):1-9 FRIDAID 1987100 doi:10.1002/rth2.12640 2475-0379 https://hdl.handle.net/10037/23804 openAccess Copyright 2021 The Author(s) Journal article Tidsskriftartikkel Peer reviewed publishedVersion 2021 ftunivtroemsoe https://doi.org/10.1002/rth2.12640 2022-01-26T23:57:05Z Background - Negatively charged procoagulant phospholipids, phosphatidylserine (PS) in particular, are vital to coagulation and expressed on the surface membrane of extracellular vesicles. No previous study has investigated the association between plasma procoagulant phospholipid clotting time (PPL CT ) and future risk of venous thromboembolism (VTE). Objectives - To investigate the association between plasma PPL CT and the risk of incident VTE in a nested case-control study. Methods - We conducted a nested case-control study in 296 VTE patients and 674 age- and sex-matched controls derived from a general population cohort (The Tromsø Study 1994–2007). PPL CT was measured in platelet-free plasma using a modified factor Xa-dependent clotting assay. Logistic regression was used to estimate odds ratio (OR) with 95% confidence intervals (CI) for VTE with PPL CT modelled as a continuous variable across quartiles and in dichotomized analyses. Results - There was a weak inverse association between plasma PPL CT and risk of VTE per 1 standard deviation increase of PPL CT (OR 0.93, 95% CI 0.80–1.07) and when comparing those with PPL CT in the highest quartile (OR 0.89, 95% CI 0.60–1.30) with those in the lowest quartile. Subjects with PPL CT >95th percentile had substantially lowered OR for VTE (OR 0.35, 95% CI 0.13–0.81). The inverse association was stronger when the analyses were restricted to samples taken shortly before the event. The risk estimates by categories of plasma PPL CT were similar for deep vein thrombosis and pulmonary embolism. Conclusion - Our findings suggest that high plasma PPL CT is associated with reduced risk of VTE. Article in Journal/Newspaper Tromsø University of Tromsø: Munin Open Research Archive Tromsø Research and Practice in Thrombosis and Haemostasis 5 8
institution Open Polar
collection University of Tromsø: Munin Open Research Archive
op_collection_id ftunivtroemsoe
language English
description Background - Negatively charged procoagulant phospholipids, phosphatidylserine (PS) in particular, are vital to coagulation and expressed on the surface membrane of extracellular vesicles. No previous study has investigated the association between plasma procoagulant phospholipid clotting time (PPL CT ) and future risk of venous thromboembolism (VTE). Objectives - To investigate the association between plasma PPL CT and the risk of incident VTE in a nested case-control study. Methods - We conducted a nested case-control study in 296 VTE patients and 674 age- and sex-matched controls derived from a general population cohort (The Tromsø Study 1994–2007). PPL CT was measured in platelet-free plasma using a modified factor Xa-dependent clotting assay. Logistic regression was used to estimate odds ratio (OR) with 95% confidence intervals (CI) for VTE with PPL CT modelled as a continuous variable across quartiles and in dichotomized analyses. Results - There was a weak inverse association between plasma PPL CT and risk of VTE per 1 standard deviation increase of PPL CT (OR 0.93, 95% CI 0.80–1.07) and when comparing those with PPL CT in the highest quartile (OR 0.89, 95% CI 0.60–1.30) with those in the lowest quartile. Subjects with PPL CT >95th percentile had substantially lowered OR for VTE (OR 0.35, 95% CI 0.13–0.81). The inverse association was stronger when the analyses were restricted to samples taken shortly before the event. The risk estimates by categories of plasma PPL CT were similar for deep vein thrombosis and pulmonary embolism. Conclusion - Our findings suggest that high plasma PPL CT is associated with reduced risk of VTE.
format Article in Journal/Newspaper
author Ramberg, Cathrine
Wilsgård, line
Latysheva, Nadezhda
Brækkan, Sigrid Kufaas
Hindberg, Kristian
Sovershaev, Timofey
Snir, Omri
Hansen, John Bjarne
spellingShingle Ramberg, Cathrine
Wilsgård, line
Latysheva, Nadezhda
Brækkan, Sigrid Kufaas
Hindberg, Kristian
Sovershaev, Timofey
Snir, Omri
Hansen, John Bjarne
Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
author_facet Ramberg, Cathrine
Wilsgård, line
Latysheva, Nadezhda
Brækkan, Sigrid Kufaas
Hindberg, Kristian
Sovershaev, Timofey
Snir, Omri
Hansen, John Bjarne
author_sort Ramberg, Cathrine
title Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
title_short Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
title_full Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
title_fullStr Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
title_full_unstemmed Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
title_sort plasma procoagulant phospholipid clotting time and venous thromboembolism risk
publisher Wiley
publishDate 2021
url https://hdl.handle.net/10037/23804
https://doi.org/10.1002/rth2.12640
geographic Tromsø
geographic_facet Tromsø
genre Tromsø
genre_facet Tromsø
op_relation Research and Practice in Thrombosis and Haemostasis
Ramberg, Wilsgård, Latysheva, Brækkan, Hindberg, Sovershaev, Snir, Hansen. Plasma procoagulant phospholipid clotting time and venous thromboembolism risk. Research and Practice in Thrombosis and Haemostasis. 2021;5(8):1-9
FRIDAID 1987100
doi:10.1002/rth2.12640
2475-0379
https://hdl.handle.net/10037/23804
op_rights openAccess
Copyright 2021 The Author(s)
op_doi https://doi.org/10.1002/rth2.12640
container_title Research and Practice in Thrombosis and Haemostasis
container_volume 5
container_issue 8
_version_ 1766219660715360256